Aleksandra Kucharczyk
Warsaw, MZ 04141, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort.
Journal: Journal of clinical medicine
Published: May 14, 2026
Lanadelumab in Hereditary Angioedema: Real-World Outcomes and Implications for Access Practices in Europe.
Journal: Journal of clinical medicine
Published: November 25, 2025
Overestimation of asthma control and misperception of the place of short-acting β2-agonists in asthma management: a prospective, real-world study among physicians in Poland.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: March 21, 2025
Predictors of excessive short-acting β2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Journal: Postepy dermatologii i alergologii
Published: September 20, 2023
Effect of Vitamin D Concentration on Course of COVID-19.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: October 03, 2022
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases.
Journal: Frontiers in medicine
Published: June 28, 2022
Pru du 1, the Bet v 1-homologue from almond, is a major allergen in patients with birch pollen associated almond allergy.
Journal: Clinical and translational allergy
Published: May 11, 2022
The Influence of the Type of Electrolyte in the Modifying Solution on the Protective Properties of Vinyltrimethoysilane/Ethanol-Based Coatings Formed on Stainless Steel X20Cr13.
Journal: Materials (Basel, Switzerland)
Published: September 20, 2021
Clinical Determinants of Successful Omalizumab Therapy in Severe Allergic Asthma Patients: 4-Year-Long, Real-Life Observation.
Journal: Journal of asthma and allergy
Published: September 15, 2020
Recurrent infections in a patient with psoriatic arthritis and hypogammaglobulinemia, treated with conventional and biologic disease-modifying anti-rheumatic drugs-a primary or secondary entity?
Journal: Clinical rheumatology
Published: March 26, 2017
Clinical and economic impact of a one-year treatment with omalizumab in patients with severe allergic asthma within a drug programme in Poland.
Journal: BMC pulmonary medicine
Published: February 12, 2017
Last Updated: 09/26/2026